Emerald Advisers’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.4M | Sell |
|
|||||
|
2025
Q2 | $24.8M | Buy |
|
|||||
|
2025
Q1 | $24.7M | Buy |
|
|||||
|
2024
Q4 | $23.3M | Sell |
|
|||||
|
2024
Q3 | $32M | Buy |
|
|||||
|
2024
Q2 | $20.9M | Sell |
|
|||||
|
2024
Q1 | $26M | Buy |
|
|||||
|
2023
Q4 | $20.5M | Sell |
|
|||||
|
2023
Q3 | $15.4M | Sell |
|
|||||
|
2023
Q2 | $17.3M | Buy |
|
|||||
|
2023
Q1 | $19.3M | Sell |
|
|||||
|
2022
Q4 | $18.9M | Sell |
|
|||||
|
2022
Q3 | $13.1M | Buy |
|
|||||
|
2022
Q2 | $14.4M | Buy |
|
|||||
|
2022
Q1 | $16.3M | Buy |
|
|||||
|
2021
Q4 | $10.7M | Sell |
|
|||||
|
2021
Q3 | $11.7M | Sell |
|
|||||
|
2021
Q2 | $17.5M | Sell |
|
|||||
|
2021
Q1 | $17.8M | Sell |
|
|||||
|
2020
Q4 | $16.7M | Buy |
|
|||||
|
2020
Q3 | $14.9M | Buy |
|
|||||
|
2020
Q2 | $10.1M | Sell |
|
|||||
|
2020
Q1 | $12.5M | Sell |
|
|||||
|
2019
Q4 | $16.1M | Buy |
|